Brazilian Develops Eye Drops to Stop Diabetes-Related Retinal Damage

Researcher Jacqueline Mendonça Lopes de Faria, from the University of Campinas (Unicamp), has developed a medicine with neuroprotective effects.

By Xiu Ying

SÃO PAULO, BRAZIL - Retinopathy is a common complication in diabetic patients. The condition is caused by excess glucose in the blood, which damages blood vessels inside the retina. This may compromise patients' vision and, in later stages, lead to complete blindness.

Currently, 13 million Brazilians have diabetes, according to data from the Brazilian Society of Diabetes (SBD). Out of this total, approximately 5.2 million suffer from impaired eyesight.

Treatments available today include laser photocoagulation . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?